AtaiBeckley Inc ATAI is reportedly attracting interest from a major U.S. pharmaceutical firm, as traders reference a Betaville alert. Despite this speculation, the company's shares dropped by 6.4% on Monday. However, ATAI has seen a year-to-date increase of 21%, indicating overall positive momentum in 2023.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.